Interestingly, Tcf4 affects expression of Nxph3, a marker that was previously shown to be lowered in PD patients and an important factor in the survival of DA neurons derived from induced pluripotent stem cells, making Tcf4 an possible target in search of stem-cell-based therapies for PD [37]. This evidence concerns the gene NXPH3 and Parkinson disease.